300920SZSE

Announcement on Proposing Shareholders' Meeting to Authorize the Board for Small-Scale Rapid Financing Matters

✨ AI Summary

Zhejiang Runyang New Materials Technology Co., Ltd. seeks shareholder approval to authorize the board to conduct small-scale rapid financing of up to RMB 300 million, not exceeding 20% of net assets. The authorization is valid until the 2026 annual shareholders' meeting. The financing will involve issuing A-shares to specific investors, with strict compliance to regulations and limitations on share transfer.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai
  1. The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
    Securities Code: 300920
    Securities Abbreviation: Runyang Technology
    Announcement Number: 2026-020

Announcement on Proposing Shareholders' Meeting to Authorize the Board for Small-Scale Rapid Financing Matters

Zhejiang Runyang New Materials Technology Co., Ltd. (hereinafter referred to as "the Company") held the 25th meeting of the 4th Board of Directors on March 30, 2026, and approved the proposal on seeking shareholders' authorization for the board to handle matters related to small-scale rapid financing. This proposal is subject to approval at the Company's 2025 annual shareholders' meeting. The specific circumstances are as follows:

1. Overview

According to the "Administrative Measures for the Registration of Securities Issuance by Listed Companies," "Rules for the Review of Securities Issuance and Listing by Listed Companies on the Shenzhen Stock Exchange," and other relevant regulations, the board proposes that the shareholders authorize the board to decide on issuing shares to specific targets for financing not exceeding RMB 300 million and not exceeding 20% of the net assets at the end of the most recent year. The authorization period is from the date of approval by the 2025 annual shareholders' meeting until the date of the 2026 annual shareholders' meeting.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.